Back

Novel risk model for predicting incident atrial fibrillation in patients at high cardiovascular risk receiving omega-3 fatty acid: sub-analysis from the STRENGTH randomized clinical trial

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (1) - Lipids: drug therapy Drug therapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Tom Kai Ming Wang

Cleveland Clinic, Cleveland (United States of America)

4 More presentations in this session

Presentation thumbnail
Discussant - Lipids: drug therapy
Presentation thumbnail
Suboptimal cardiovascular risk management in cancer survivors: analysis of statin prescription patterns following coronary calcium scoring
Doctor C. Soh (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Icosapent ethyl eligible patients following acute coronary syndrome are at increased risk of myocardial re-infarction: Data from CALLINICUS-Hellas registry
Professor L. Rallidis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Pleiotropic effects of inclisiran on arterial structural and functional parameters
Doctor M. Bellomare (Milan, IT)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (1) - Lipids: drug therapy

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Predicting incident atrial fibrillation using AI-ECG: enhancing risk stratification for stroke prevention
thumbnail
Congress Presentation
Left atrial function for predicting atrial fibrillation: a machine learning approach
thumbnail
Congress Presentation
Left atrial function and polygenic risk scores for predicting atrial fibrillation and related stroke/systemic embolism

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources